Julie A. Lynch

7.9k total citations
108 papers, 1.1k citations indexed

About

Julie A. Lynch is a scholar working on Pulmonary and Respiratory Medicine, Genetics and Oncology. According to data from OpenAlex, Julie A. Lynch has authored 108 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Pulmonary and Respiratory Medicine, 31 papers in Genetics and 25 papers in Oncology. Recurrent topics in Julie A. Lynch's work include Prostate Cancer Treatment and Research (17 papers), BRCA gene mutations in cancer (15 papers) and Prostate Cancer Diagnosis and Treatment (14 papers). Julie A. Lynch is often cited by papers focused on Prostate Cancer Treatment and Research (17 papers), BRCA gene mutations in cancer (15 papers) and Prostate Cancer Diagnosis and Treatment (14 papers). Julie A. Lynch collaborates with scholars based in United States, United Kingdom and Sweden. Julie A. Lynch's co-authors include Brygida Berse, Scott L. DuVall, Scott M. Damrauer, Muin J. Khoury, Kyung Min Lee, Benjamin F. Voight, Brent S. Rose, John Kautter, Nicole M. Coomer and W. David Dotson and has published in prestigious journals such as Circulation, Nature Communications and Nature Genetics.

In The Last Decade

Julie A. Lynch

91 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Julie A. Lynch United States 20 338 297 269 207 174 108 1.1k
Charnita Zeigler‐Johnson United States 18 607 1.8× 222 0.7× 352 1.3× 154 0.7× 281 1.6× 62 1.4k
Lars‐Erik Rutqvist Sweden 18 170 0.5× 296 1.0× 788 2.9× 194 0.9× 136 0.8× 25 1.2k
Xiao‐Feng He China 21 120 0.4× 129 0.4× 263 1.0× 196 0.9× 475 2.7× 97 1.1k
Zachary S. Fredericksen United States 25 187 0.6× 216 0.7× 468 1.7× 269 1.3× 591 3.4× 42 1.5k
Andreas Brandt Germany 23 259 0.8× 217 0.7× 417 1.6× 243 1.2× 320 1.8× 51 1.7k
Elvira D’Andrea United States 22 79 0.2× 257 0.9× 155 0.6× 100 0.5× 145 0.8× 62 1.1k
Tal Sella Israel 18 174 0.5× 128 0.4× 375 1.4× 224 1.1× 128 0.7× 66 1.0k
Mehmet Artaç Türkiye 18 202 0.6× 68 0.2× 528 2.0× 112 0.5× 184 1.1× 127 1.1k
Falk C. Thiel Germany 22 143 0.4× 164 0.6× 203 0.8× 125 0.6× 260 1.5× 68 1.4k
K S Chia Singapore 15 198 0.6× 190 0.6× 446 1.7× 105 0.5× 118 0.7× 31 1.0k

Countries citing papers authored by Julie A. Lynch

Since Specialization
Citations

This map shows the geographic impact of Julie A. Lynch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Julie A. Lynch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Julie A. Lynch more than expected).

Fields of papers citing papers by Julie A. Lynch

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Julie A. Lynch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Julie A. Lynch. The network helps show where Julie A. Lynch may publish in the future.

Co-authorship network of co-authors of Julie A. Lynch

This figure shows the co-authorship network connecting the top 25 collaborators of Julie A. Lynch. A scholar is included among the top collaborators of Julie A. Lynch based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Julie A. Lynch. Julie A. Lynch is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rizvi, M. Moshahid Alam, Liang Liu, Erin M. Warshaw, et al.. (2025). Anatomical Locations of Keratinocyte Carcinomas Among United States Veterans Affairs Healthcare System Patients in Minnesota: A Cross‐Sectional Study. Experimental Dermatology. 34(12). e70196–e70196.
2.
Lynch, Julie A., Rebecca A. Hubbard, Patrick R. Alba, et al.. (2024). Racial Differences in Germline Genetic Testing Completion Among Males With Pancreatic, Breast, or Metastatic Prostate Cancers. Journal of the National Comprehensive Cancer Network. 22(4). 237–243. 6 indexed citations
3.
Lipska, Kasia J., Carol Oladele, Barbara Gulanski, et al.. (2024). Association of Race and Ethnicity with Prescriptions for Continuous Glucose Monitoring Systems Among a National Sample of Veterans with Diabetes on Insulin Therapy. Diabetes Technology & Therapeutics. 26(12). 908–917. 2 indexed citations
4.
Smith, Johanna L., Catherine Tcheandjieu, Ozan Dikilitas, et al.. (2024). Multi-Ancestry Polygenic Risk Score for Coronary Heart Disease Based on an Ancestrally Diverse Genome-Wide Association Study and Population-Specific Optimization. Circulation Genomic and Precision Medicine. 17(3). e004272–e004272. 8 indexed citations
5.
Pagadala, Meghana S., Asona Lui, Julie A. Lynch, et al.. (2024). Healthy lifestyle and prostate cancer risk in the Million Veteran Program. Cancer. 130(20). 3496–3505. 4 indexed citations
6.
Bowles, Annie C., Anil Vachani, Brent S. Rose, et al.. (2024). An NLP Framework for the Extraction of Concept Measurements from Radiology and Pathology Notes. Studies in health technology and informatics. 310. 1446–1447. 1 indexed citations
7.
Lynch, Julie A., J M Petersen, Lori Hoffman-Hōgg, et al.. (2023). On-Site Nurse-Led Cancer Genetics Program Increases Cancer Genetic Testing Completion in Black Veterans. JCO Oncology Practice. 19(8). 637–644. 6 indexed citations
8.
Valle, Luca, Nicholas G. Nickols, Ryan Hausler, et al.. (2023). Actionable Genomic Alterations in Prostate Cancer Among Black and White United States Veterans. The Oncologist. 28(6). e473–e477. 5 indexed citations
9.
Litkowski, Elizabeth, Mark W. Logue, Rui Zhang, et al.. (2023). Mendelian randomization study of diabetes and dementia in the Million Veteran Program. Alzheimer s & Dementia. 19(10). 4367–4376. 16 indexed citations
10.
Pagadala, Meghana S., Asona Lui, Julie A. Lynch, et al.. (2023). Healthy lifestyle, Agent Orange exposure, and inherited PCa risk: An analysis of the Million Veteran Program.. Journal of Clinical Oncology. 41(6_suppl). 210–210.
11.
Hung, Anna, Julie A. Lynch, Tori Anglin-Foote, et al.. (2023). Development and Validation of a Tool to Identify Patients Diagnosed With Castration-Resistant Prostate Cancer. JCO Clinical Cancer Informatics. 7(7). e2300085–e2300085. 2 indexed citations
12.
Pagadala, Meghana S., Julie A. Lynch, Roshan Karunamuni, et al.. (2022). Polygenic risk of any, metastatic, and fatal prostate cancer in the Million Veteran Program. JNCI Journal of the National Cancer Institute. 115(2). 190–199. 22 indexed citations
13.
Litkowski, Elizabeth, Mark W. Logue, Rui Zhang, et al.. (2022). A Diabetes Genetic Risk Score Is Associated With All-Cause Dementia and Clinically Diagnosed Vascular Dementia in the Million Veteran Program. Diabetes Care. 45(11). 2544–2552. 7 indexed citations
14.
Levin, Michael G., Derek Klarin, Venexia Walker, et al.. (2021). Association Between Genetic Variation in Blood Pressure and Increased Lifetime Risk of Peripheral Artery Disease. Arteriosclerosis Thrombosis and Vascular Biology. 41(6). 2027–2034. 18 indexed citations
15.
Daghlas, Iyas, Ville Karhunen, Verena Zuber, et al.. (2021). Genetic Evidence for Repurposing of GLP1R (Glucagon‐Like Peptide‐1 Receptor) Agonists to Prevent Heart Failure. Journal of the American Heart Association. 10(13). e020331–e020331. 19 indexed citations
16.
Levin, Michael G., Verena Zuber, Venexia Walker, et al.. (2021). Prioritizing the Role of Major Lipoproteins and Subfractions as Risk Factors for Peripheral Artery Disease. Circulation. 144(5). 353–364. 38 indexed citations
17.
Qiao, Edmund M., Julie A. Lynch, Kyung Min Lee, et al.. (2021). Evaluating Prostate-Specific Antigen Screening for Young African American Men With Cancer. JNCI Journal of the National Cancer Institute. 114(4). 592–599. 7 indexed citations
18.
Thom, Christopher S., Michael G. Levin, Scott M. Damrauer, et al.. (2020). Genetic determinants of increased body mass index mediate the effect of smoking on increased risk for type 2 diabetes but not coronary artery disease. Human Molecular Genetics. 29(19). 3327–3337. 6 indexed citations
19.
Small, Aeron, Jennifer E. Huffman, Derek Klarin, et al.. (2020). Mendelian Randomization Analysis of Hemostatic Factors and Their Contribution to Peripheral Artery Disease—Brief Report. Arteriosclerosis Thrombosis and Vascular Biology. 41(1). 380–386. 10 indexed citations
20.
Lynch, Julie A., Muin J. Khoury, Ann M. Borzecki, et al.. (2013). Utilization of epidermal growth factor receptor (EGFR) testing in the United States: a case study of T3 translational research. Genetics in Medicine. 15(8). 630–638. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026